Insilicom LLC
Tallahassee, FL
- UEI
- UEZ1NQZ388J6
- CAGE
- 702F0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 8117 Viburnum Ct S, Tallahassee, FL 32312, USA
- Website
- insilicom.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Information Technology
- Software & Services
- Internet Software & Services
- SIC code
- 73 Business Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Leveraging ikraph for personalized nutrition planning in cancer prevention and management | Interior Business Center | $600,000 | |
| Sbir topic 136 - insilicom | National Institute of Allergy and Infectious Diseases | $300,000 | |
| Apto: constructing causal knowledge graphs for assessing and predicting technology outcomes -assessing and predicting… | National Science Foundation | $5,798,454 | |
| Sbir FY24 concept award-drug repurposing for rare cancers using a large-scale, high-quality biomedical knowledge graph | National Cancer Institute | $355,000 | |
| Sbir phase i: knowledge graph-powered information retrieval and causal inference -the broader/commercial impact of… | National Science Foundation | $275,000 |
About Insilicom LLC
Insilicom LLC, a woman-owned, minority-owned small business based in Tallahassee, Florida, develops natural language processing and artificial intelligence tools that transform unstructured scientific literature into structured knowledge graphs for biomedical research and drug discovery. The firm operates as a prime recipient on federal contracts and grants only (100% of recent awards are prime) and competes under small business set-asides and SBIR programs through the National Institutes of Health, National Science Foundation, and related federal research agencies.
Insilicom's corporate structure is a limited liability partnership with woman-owned and Asian-Pacific American-owned designations. The company's concrete capability portfolio centers on biomedical knowledge graph construction using advanced NLP and machine learning to enable causal inference, information retrieval, and technology-outcome prediction in healthcare and drug discovery domains. Representative work includes a $600,000 definitive contract awarded by NIH on February 23, 2026 (completion March 1, 2028) to leverage the company's proprietary iKraph technology for personalized nutrition planning in cancer prevention and management under a Total Small Business set-aside; a $355,000 SBIR Phase I contract from the National Cancer Institute (award February 15, 2024) for drug repurposing targeting rare cancers using large-scale biomedical knowledge graphs; and a $300,000 SBIR Topic 136 contract from the National Institute of Allergy and Infectious Diseases (award September 5, 2024) for enhancing biomedical knowledge graphs in infectious and immune-mediated disease research.
Customer concentration reflects Insilicom's research-agency focus. The National Institutes of Health (including the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of Environmental Health Sciences) accounts for four awards totaling $1.255 million in combined potential value; the National Science Foundation holds three awards. These six customer entities represent 88% of awards by count and 100% of combined potential value. Two awards (combined potential value $600,000) face ultimate completion within the next twenty-four months and therefore expose Insilicom to recompete risk in that window.
Federal grant work dominates the footprint. NSF awarded Insilicom a cooperative agreement (August 1, 2024, completion July 31, 2027) under the APTO program to construct causal knowledge graphs for assessing and predicting technology outcomes in healthcare and drug discovery, complemented by NSF SBIR Phase I Project Grant funding ($275,000, award February 15, 2024) for knowledge-graph-powered information retrieval and causal inference systems. The National Institute of Environmental Health Sciences issued a Project Grant (September 1, 2023) for constructing large-scale biomedical knowledge graphs from PubMed abstracts and PMC full-text articles. Service Contract Inventory data shows minimal SCI-reported activity—0.4 FTEs captured in FY2024 as a named subcontractor on a single record—consistent with Insilicom's profile as a research and development firm operating primarily under federal grants and firm-fixed-price research contracts rather than labor-hour service contracts.
Quick answers
What is Insilicom LLC's UEI?
Insilicom LLC's Unique Entity ID (UEI) in SAM.gov is UEZ1NQZ388J6.
What is Insilicom LLC's CAGE code?
Insilicom LLC's CAGE code is 702F0.
What is Insilicom LLC's primary NAICS code?
Insilicom LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Insilicom LLC located?
Insilicom LLC's physical address in SAM.gov is 8117 Viburnum Ct S, Tallahassee, FL 32312, USA.
Is Insilicom LLC registered in SAM.gov?
Yes. Insilicom LLC's SAM.gov registration is active through January 22, 2027.
What is Insilicom LLC's most recent federal award?
Insilicom LLC's most recent federal contract award is Leveraging ikraph for personalized nutrition planning in cancer prevention and management (140D0426C0006), from Interior Business Center, on February 23, 2026.
On GovTribe
See Insilicom LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors